1. Home
  2. PMCB vs MHUA Comparison

PMCB vs MHUA Comparison

Compare PMCB & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • MHUA
  • Stock Information
  • Founded
  • PMCB 1996
  • MHUA 1990
  • Country
  • PMCB United States
  • MHUA China
  • Employees
  • PMCB N/A
  • MHUA N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • MHUA Medical Specialities
  • Sector
  • PMCB Health Care
  • MHUA Health Care
  • Exchange
  • PMCB Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • PMCB 11.4M
  • MHUA 10.2M
  • IPO Year
  • PMCB N/A
  • MHUA 2022
  • Fundamental
  • Price
  • PMCB $1.24
  • MHUA $0.32
  • Analyst Decision
  • PMCB
  • MHUA
  • Analyst Count
  • PMCB 0
  • MHUA 0
  • Target Price
  • PMCB N/A
  • MHUA N/A
  • AVG Volume (30 Days)
  • PMCB 15.0K
  • MHUA 56.0K
  • Earning Date
  • PMCB 03-17-2025
  • MHUA 04-23-2025
  • Dividend Yield
  • PMCB N/A
  • MHUA N/A
  • EPS Growth
  • PMCB N/A
  • MHUA 29.93
  • EPS
  • PMCB 1.29
  • MHUA 0.37
  • Revenue
  • PMCB N/A
  • MHUA $94,252,537.00
  • Revenue This Year
  • PMCB N/A
  • MHUA N/A
  • Revenue Next Year
  • PMCB N/A
  • MHUA N/A
  • P/E Ratio
  • PMCB $1.00
  • MHUA $0.90
  • Revenue Growth
  • PMCB N/A
  • MHUA N/A
  • 52 Week Low
  • PMCB $1.22
  • MHUA $0.25
  • 52 Week High
  • PMCB $2.55
  • MHUA $1.47
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 30.59
  • MHUA 42.44
  • Support Level
  • PMCB $1.22
  • MHUA $0.33
  • Resistance Level
  • PMCB $1.40
  • MHUA $0.36
  • Average True Range (ATR)
  • PMCB 0.13
  • MHUA 0.02
  • MACD
  • PMCB -0.04
  • MHUA -0.00
  • Stochastic Oscillator
  • PMCB 3.90
  • MHUA 6.28

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: